Literature DB >> 11779728

Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia.

Jan Hayon1, Corinne Figliolini, Alain Combes, Jean-Louis Trouillet, Najibi Kassis, Marie Christine Dombret, Claude Gibert, Jean Chastre.   

Abstract

Results of routine microbiologic cultures of specimens obtained before the onset of ventilator-associated pneumonia (VAP) in intensive care unit (ICU) patients might help to identify the causative microorganisms and thus to select effective initial antimicrobial therapy. To test this hypothesis, we prospectively studied 125 consecutive VAP episodes for which the causative microorganisms were determined using bronchoscopic techniques. Upon entry into the study, each patient's hospital chart was reviewed and culture results of all previously obtained microbiologic specimens were recorded (mean number +/- SD per patient, 45 +/- 38). A total of 220 microorganisms were cultured at significant concentrations (> or = 10(3)/10(4) colony-forming units [cfu]/ml) from bronchoscopic specimens and considered responsible for pneumonia. Of these 220 organisms, only 73 (33%) were recovered before VAP onset, sometimes from multiple sites in the same patient but mainly from prior respiratory secretion cultures (n = 53). Also previously isolated were 342 organisms that were not responsible for VAP, making prospective identifications of the true pathogens difficult. Among the 102 episodes for which prior respiratory secretion culture results had been obtained (mean time before VAP onset, 8 +/- 9 d), all the organisms ultimately responsible for pneumonia were previously recovered from only 36 (35%) of these specimens. Based on these data, the contribution of routine microbiologic specimens in guiding initial antimicrobial therapy decisions for patients with suspected VAP appears limited.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779728     DOI: 10.1164/ajrccm.165.1.2105077

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  28 in total

1.  Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability.

Authors:  Carolina A M Schurink; Christianne A Van Nieuwenhoven; Jan A Jacobs; Maja Rozenberg-Arska; Hans C A Joore; Erik Buskens; Andy I M Hoepelman; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2003-10-18       Impact factor: 17.440

Review 2.  The Lung Microbiome and Its Role in Pneumonia.

Authors:  Benjamin G Wu; Leopoldo N Segal
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

3.  Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures.

Authors:  Pieter Depuydt; Dominique Benoit; Dirk Vogelaers; Geert Claeys; Gerda Verschraegen; Koenraad Vandewoude; Johan Decruyenaere; Stijn Blot
Journal:  Intensive Care Med       Date:  2006-09-16       Impact factor: 17.440

4.  Ventilator-associated pneumonia: diagnosis, treatment, and prevention.

Authors:  Steven M Koenig; Jonathon D Truwit
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

5.  Maximizing rates of empiric appropriate antibiotic therapy with minimized use of broad-spectrum agents: are surveillance cultures the key?

Authors:  S Blot; P Depuydt; D Vogelaers
Journal:  Intensive Care Med       Date:  2008-08-19       Impact factor: 17.440

6.  The role of surveillance cultures in the prediction of susceptibility patterns of Gram-negative bacilli in the intensive care unit.

Authors:  H Baba; G R Nimmo; A M Allworth; R J Boots; Y Hayashi; J Lipman; D L Paterson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-11       Impact factor: 3.267

Review 7.  Value of lower respiratory tract surveillance cultures to predict bacterial pathogens in ventilator-associated pneumonia: systematic review and diagnostic test accuracy meta-analysis.

Authors:  Nele Brusselaers; Sonia Labeau; Dirk Vogelaers; Stijn Blot
Journal:  Intensive Care Med       Date:  2012-11-28       Impact factor: 17.440

8.  Variation of infected cell count in bronchoalveolar lavage and timing of ventilator-associated pneumonia.

Authors:  Hervé Dupont; Viviane Chalhoub; Gaëtan Plantefève; Cyrille De Vaumas; Nathalie Kermarrec; Catherine Paugam-Burtz; Jean Mantz
Journal:  Intensive Care Med       Date:  2004-05-13       Impact factor: 17.440

9.  Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia.

Authors:  P Depuydt; D Benoit; D Vogelaers; J Decruyenaere; D Vandijck; G Claeys; G Verschraegen; S Blot
Journal:  Intensive Care Med       Date:  2007-12-08       Impact factor: 17.440

10.  Blind and bronchoscopic sampling methods in suspected ventilator-associated pneumonia. A multicentre prospective study.

Authors:  Hervé Mentec; Laetitia May-Michelangeli; Antoine Rabbat; Emmanuelle Varon; Françoise Le Turdu; Gérard Bleichner
Journal:  Intensive Care Med       Date:  2004-04-20       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.